Actavis

Actavis is a global integrated pharmaceutical company that develops, manufactures and distributes generics, brands and biosimilars.

The company is headquartered in Dublin, Ireland, with an administrative office in Parsippany, New Jersey, USA. New Actavis, Inc. is a strong combination of two successful companies in their development - Watson Pharmaceuticals, Inc. and private company Actavis Group. The global portfolio consists of more than 750 molecules in 1700 doses and formulations in more than 60 countries.

Actavis operates the world's third largest generics business and is one of the top 3 pharmaceutical companies in 12 global markets.

The company is also engaged in the development of biosimilar products in oncology and other therapeutic areas.

Actavis has been represented in Ukraine since 1999. More than 100 drugs for the treatment of cardiovascular diseases and the nervous system, as well as a number of over-the-counter drugs, are registered on the Ukrainian market.